These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 17269421)
1. [Clinical and laboratory criteria for assessing the efficacy of Essliver Forte for patients with combined liver and gall bladder pathologies]. Kozlova IV; Antonian AA; Volkov SV Eksp Klin Gastroenterol; 2006; (4):31-6, 115-6. PubMed ID: 17269421 [TBL] [Abstract][Full Text] [Related]
2. [Effect of the concomitant pathologies of the hepatobiliary system on the ulcer course and substantiation of the use of Essliver Forte as a part of the complex therapy]. Shkatova EIu; Mufazdalova IV; Khokhlacheva NA Eksp Klin Gastroenterol; 2006; (4):43-7. PubMed ID: 17269423 [No Abstract] [Full Text] [Related]
3. [The role of stomach epithelial cells being immunopositive for NO synthase in the formation of chronic cholecystitis]. Osadchuk MA; Kon'kov AV; Lipatov TE Eksp Klin Gastroenterol; 2004; (5):26-30, 147. PubMed ID: 15770857 [TBL] [Abstract][Full Text] [Related]
5. [Modern approaches to the therapy of biliary system diseases]. Galiullin AR; Khakamova GA; Uliamaeva VV; Latypova GA; Gur'ev DA; Volevach LV Eksp Klin Gastroenterol; 2010; (4):109-13. PubMed ID: 20623959 [TBL] [Abstract][Full Text] [Related]
6. [Effects of laser reflex therapy on a motor function of the gall bladder and physical properties of bile in patients with chronic acalculous cholecystitis]. Burduli NM; Raniuk LG Ter Arkh; 2009; 81(2):57-61. PubMed ID: 19334492 [TBL] [Abstract][Full Text] [Related]
7. Clinical-epidemiological features, diagnostics, treatment of chronic viral hepatitises, combined with opisthorchosis in inhabitants of Siberia and the Northern regions of Russia. Paltsev AI Alaska Med; 2007; 49(2 Suppl):153-60. PubMed ID: 17929626 [TBL] [Abstract][Full Text] [Related]
8. [Effect of essential phospholipids (Essliver Forte) on the level of cholesterol and blood serum lipoproteins in bile duct diseases]. Kozlova NM; Tiuriumin IaL; Kulinskiĭ VI; Leonova ZA Eksp Klin Gastroenterol; 2006; (6):73-6. PubMed ID: 17612099 [No Abstract] [Full Text] [Related]
10. [Assessment of the efficacy of mebeverine in the complex therapy of chronic noncalculolis cholecystitis and biliary dysfunction]. Maev IV; Samsonov AA; Ul'iankina EV; Nikushkina IN; Salova LM; Shakh IuS Eksp Klin Gastroenterol; 2007; (2):120-5. PubMed ID: 17539356 [No Abstract] [Full Text] [Related]
11. [Use of tykveol in the treatment of impaired biliary tract function in patients with chronic non-calculous cholecystitis]. Vakhrushev IaM; Petrova LI Klin Med (Mosk); 2004; 82(10):49-51. PubMed ID: 15584601 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy of an autonomic electronic stimulator of the gastrointestinal tract in patients with chronic acalculous cholecystitis]. Buntin SE Vopr Kurortol Fizioter Lech Fiz Kult; 2004; (5):15-7. PubMed ID: 15575530 [No Abstract] [Full Text] [Related]
14. [Assessment of the effectiveness of laser reflexotherapy in combined treatment of patients with chronic acalculous cholecystitis]. Burduli NM; Raniuk LG Eksp Klin Gastroenterol; 2014; (8):78-83. PubMed ID: 25911917 [TBL] [Abstract][Full Text] [Related]